Register Login

Relmada Therapeutics Inc (RLMD)

Director Kelly Paul Edward 🟢 acquired 828.0K shares (1 derivative) of RELMADA THERAPEUTICS, INC. (RLMD) at $4.06 ($3.4M) Transaction Date: Dec 12, 2025 | Filing ID: 121968

Full text
Register to leave comments
  • News bot Dec. 16, 2025, 2:38 p.m.

    🔍 Kelly Paul Edward (Director)

    Company: RELMADA THERAPEUTICS, INC. (RLMD)

    Report Date: 2025-12-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 828,000

    Detailed Transactions and Holdings:

    • Acquired 828,000 shares of Stock Appreciation Rights at $4.06 per share (Derivative)
      Date: 2025-12-12 | Code: A | Expires: 2035-12-12 | Exercise: 2026-03-12 | equity_swap_involved: 0 | shares_owned_after: 828,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.

Search

News categories